the development of the IgG subclass response in childhood. Journal of Infectious Diseases 1990;162:1128-1135.

Henson PM. Antibody and immune-complex-mediated allergic and inflammatory reactions. In: Lachmann PJ, Peters DK, eds. Clinical Aspects of Immunology, 4th edition. Oxford: Blackwell: 1982.

Hirsch RL, Mokhtarian F, Griffin DE, Brooks BR, Hess J, Johnson RT. Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production. Clinical Immunology and Immunopathology 1981;21:341-350.

Institute of Medicine. Adverse Effects of Pertussis and Rubella Vaccines. Washington, DC: National Academy Press; 1991.

Jaber L, Shohat M, Mimouni M. Infectious episodes following diphtheria-pertussis-tetanus vaccination: a preliminary observation in infants. Clinical Pediatrics 1988;27:491-494.

Joffe LS, Glode MP, Gutierrez MK, Wiesenthal A, Luckey DW, Harken L. Diphtheria-tetanus toxoids-pertussis vaccination does not increase the risk of hospitalization with an infectious illness. Pediatric Infectious Disease Journal 1992;11:730-735.

Kniker WT. Anaphylaxis in children and adults. In: Bierman CW, Pearlman DW, eds. Allergic Diseases from Infancy to Adulthood. Philadelphia: W.B. Saunders Co.; 1988.

Kupers TA, Petrich JM, Holloway AW, St. Geme JW, Jr. Depression of tuberculin delayed hypersensitivity by live attenuated mumps virus. Journal of Pediatrics 1970;76:716-721.

Munyer TP, Mangi RJ, Dolan T, Kantor FS. Depressed lymphocyte function after measles-mumps-rubella vaccination. Journal of Infectious Diseases 1975;134:75-78.

Nicholson JKA, Holman RC, Jones BM, McDougal JS, Sprauer MA, Markowitz LE. The effect of measles-rubella vaccination on lymphocyte populations and subpopulations in HIV-infected and healthy individuals. Journal of Acquired Immune Deficiency Syndromes 1992;5:528-537.

Pearlman DS, Bierman CW. Allergic disorders. In: Stiehm ER, ed. Immunologic Disorders in Infants and Children, 3rd edition. Philadelphia: W.B. Saunders Co.; 1989.

Starr S, Berkovich S. Effects of measles, gamma-globulin-modified measles and vaccine measles on the tuberculin test. New England Journal of Medicine 1964;270:386-391.

Storsaeter J, Olin P, Renemar B, Lagergard T, Norberg R, Romanus V, Tiru M. Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden. Pediatric Infectious Disease Journal 1988;7:637-645.

Toraldo R, Tolone C, Catalanotti P, Ianniello R, D'Avanzo M, Canino G, et al. Effect of measles-mumps-rubella vaccination on polymorphonuclear neutrophil functions in children. Acta Paediatrica 1992;81:887-890.

U.S. Department of Health and Human Services. U.S. Public Health Service, National Vaccine Injury Compensation Program; Revision of the Vaccine Injury Table; proposed rule. Federal Register, 42 CFR Part 100, August 14, 1992;57(158):36877-36885.

Ward B J, Johnson RT, Vaisberg A, Jauregui E, Griffin DE. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clinical Immunology and Immunopathology 1991:61:236-248.

Wiggins CA, Dykewicz MS, Patterson R. Idiopathic anaphylaxis: a review. Annals of Allergy 1989;62:1-4.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement